Update on bronchiectasis

Symposium
Chairs: A. End (Vienna, Austria), J. Lordan (Newcastle-Upon-Tyne, United Kingdom)
Aims: The audience will obtain information on new immunological concepts with regard to epithelial mesenchymal transition, microbiosome/immunological interactions, potential impact of reflux disease. In addition, an update will be provided on current antibiotic use (inhalation, etc.), immunomodulatory therapy, when to treat surgically and when to consider lung transplantation.
New insights into pathogenesis of bronchiectasis
C. Ward (Newcastle-Upon-Tyne, United Kingdom)
Slide presentationMultimedia files
Slide presentationMultimedia files
Indications for surgical treatment in limited bronchiectasis
D. Subotic (Belgrade, Republic of Serbia)
Slide presentation
Slide presentation
Lung transplantation for diffuse bronchiectasis
M. Iversen (Copenhagen, Denmark)
Slide presentationMultimedia files
Slide presentationMultimedia files